ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Stock
Total 13F shares
7,972,838
Share change
+1,013,745
Total reported value
$11,188,538
Price per share
$1.41
Number of holders
44
Value change
+$2,089,935
Number of buys
32
Number of sells
4

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q1 2021

As of 31 Mar 2021, ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,972,838 shares. The largest 10 holders included Canaan Partners X LLC, FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., TWO SIGMA INVESTMENTS, LP, HRT FINANCIAL LP, Insight Advisors, LLC/ PA, FineMark National Bank & Trust, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, and Virtu Financial LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.